Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Cancer
- Disease
- HIV / AIDs
- Immune
- Therapeutic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 304737
License Grant
Licensor grants, and shall procure that each of its relevant Affiliates shall grant
— an exclusive license (or sublicense, under the Licensor Patent Rights and the Licensor Know-How to the extent specific to the Compound and the Product; and,
— a non-exclusive license, under the Licensor Know-How that is not specific but is related to one or both of the Compounds and/or the Products; in each case, to make, have made, use, sell, have sold, offer for sale, and import Compounds and Products in the Field in the Territory during the Term.
License Property
Licensor owns or otherwise controls intellectual property relating to the proprietary therapeutic composition known as Low Dose Naltrexone or Lodonal or LDN and also owns or otherwise controls to the composition known as Methionine Enkephalin or MENK.
Product shall mean any pharmaceutical composition or preparation, in any and all dosage forms, in final form containing a Compound as an active ingredient, that utilizes or is covered by the Licensor Patent Rights or Know-How. Specifically formulated Lodonal or MENK.
Field of Use
The field of use is in veterinary applications for all indications world-wide.
The licensing agreement is the rights to research, develop and commercialize Lodonal (IRT=103) and IRT-101 for the for the treatment of immune disfunction, inflammatory diseases and cancer in companion animals.
IPSCIO Record ID: 344526
License Grant
Licensor, an individual in China, grants to Licensee an exclusive worldwide license, wi1th a right to grant sublicenses, in all fields under the Licensed Patents to make, have made, use, sell, offer for sale and import Licensed Products and to use Licensed Processes.
License Property
The intellectual property includes patents titles
Met-enkephalin, its application in in treating leukemia and other blood cancers;
Met-enkephalin, its application in preparation of human and animal vaccine;
A nasal spray formulation containing Met enkephalin;
Low dose naltrexone, combined with MENK, its application in preparation of anticancer drug;
Compound met-enkephalin as a drug for colon cancer and pancreatic cancer; and,
Naltrexone as well as analogues being anticancer drug;
and, any other intellectual property of Licensor relating to !he following Multiple, Cancer of the prostate. Lymphoproliferative syndrome. including such diseases as malignant lymphoma. chronic lymphocytic leukemia, Hodgkins lymphoma, and non-Hodgkins lymphoma and all reissues or modification. reexaminations. or other related Chinese. PTC or U.S. patent filings directed to the same subject matter.
Licensed Product means any protocols, methods, therapies, or patient information.
Field of Use
The field of use is cancer and other related diseases.
IPSCIO Record ID: 237979
License Grant
The Licensor grants to Licensee a royalty-bearing, exclusive, non-sublicensable, non-transferable license under the Licensed Technology solely to make Product from Licensed API ( Active Pharmaceutical Ingredient) in Africa, Central America, South America and Caribbean, market, sell, have sold, offer for sale, export from Africa, Central America, South America and Caribbean and import such Product made from Licensed API in the Territory for use in the Field, and market, sell, have sold, offer for sale, export from Africa, Central America, South America and Caribbean and import such Product made from Licensed API for use in animals in Field in the Territory, including the United States. API means, individually and collectively, the following active pharmaceutical ingredients naltrexone and MENK, the structures of each such compounds are disclosed in the Patents including the treatment of patients with immune dysfunction or immune dysregulation indication.
License Property
The Licensor wishes to facilitate access to its proprietary compounds, immediate release low dose naltrexone (Lodonal) and Met-Enkelphline (MENK), as a monotherapy and adjunctive therapy in the treatment of patients with immune dysfunction or immune dysregulation indication, including but not limited to HIV/AID, Crohn’s Disease, Fibromyalgia, Infectious Disease, Malaria, and Cancer, in low income countries.
Field of Use
Field means with respect to a Product, any use that is consistent with the label approved by the FDA or applicable foreign regulatory authority in the country of sale for the use of such Product, including the use of NTX Product for the treatment of immune dysfunction and immune dysfunction. As it relates to use of a Product in animals, the Field shall include any use that is consistent with the label approved by the Office of Minor Use and Minor Species or applicable foreign regulatory authority in the country of sale for the use of such Product.
Licensee is a pharmaceutical company, committed to the commercialization of our patented therapies focused on the activation and re-balancing of the body’s immune system.
IPSCIO Record ID: 203285
License Grant
Licensor grants an exclusive, worldwide, non-transferable, license, with the right to sublicense, under the Licensor Patent Rights and Know-How to make, use, including in activities directed at the research and Development of Licensed Compounds, have made, sell, have sold, offer to sell, export, import and otherwise exploit or Commercialize Licensed Compounds and Licensed Products in the Field in the Territory.
Licensor grants a non-transferable, non-exclusive license, with the right to sublicense, under the Licensor Other Patent Rights solely to the extent reasonably necessary to make, use (including in activities directed at the research and Development of Licensed Compounds), have made, sell, offer to sell, export and import and otherwise exploit or Commercialize Licensed Compounds and Licensed Products in the Field in the Territory.
License Property
MS564929 Toxicology Studies means the two (2) toxicology reports due n the IND covering the BMS compound designated BMS564929, specifically the 6 onth oral toxicology studies in rats and dogs.
6,670,386 – Bicyclic modulators of androgen receptor function
The licensed compounds and patents relate to controlling various diseases and cancers.
Field of Use
The Field means the diagnosis, prevention, treatment or control of any human or animal disease, disorder or condition, excluding the prevention, treatment or control of any human or animal hyperproliferative disease, disorder or condition. For purposes of clarity, hyperproliferative diseases, disorders and conditions are those diseases, disorders or conditions which are characterized by an abnormal increase in the proliferation or accumulation of cells and include conditions such as cancers and benign hyperplasia, but not diseases, disorders or conditions incident to an abnormal increase in the proliferation or accumulation of cells.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
